Holen Sie sich die Stockscreener-App
2.9747
3.07%
-0.0853
Finanzdaten der Anixa Biosciences Inc-Aktie (ANIX)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
| Enddatum des Zeitraums | 2026-01-31 | 2025-10-31 | 2025-07-31 | 2025-04-30 | 2025-01-31 |
| Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
| Revenues |
-
|
- | - | - | - |
| Research and Development |
3.50%
1.102
|
1.142 | 1.055 | 1.322 | 1.552 |
| Costs And Expenses |
5.56%
2.716
|
2.876 | 2.436 | 3.003 | 3.386 |
| Operating Income/Loss |
5.56%
-2.716
|
-2.876 | -2.436 | -3.003 | -3.386 |
| Income/Loss From Continuing Operations Before Tax |
5.03%
-2.585
|
-2.722 | -2.28 | -2.813 | -3.213 |
| Income/Loss From Continuing Operations After Tax |
5.03%
-2.585
|
-2.722 | -2.28 | -2.813 | -3.213 |
Net Income/Loss
|
5.03%
-2.585
|
-2.722 | -2.28 | -2.813 | -3.213 |
| Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
| Attributable To Noncontrolling Interest |
25.93%
-0.02
|
-0.027 | -0.022 | -0.023 | -0.029 |
| Basic Average Shares |
203.04%
33.24
|
-32.26 | 32.48 | 32.20 | 32.20 |
| Diluted Average Shares |
203.04%
33.24
|
-32.26 | 32.48 | 32.20 | 32.20 |
| Basic Earnings Per Share |
11.11%
-0.08
|
-0.09 | -0.07 | -0.09 | -0.10 |
| Diluted Earnings Per Share |
11.11%
-0.08
|
-0.09 | -0.07 | -0.09 | -0.10 |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
5.78%
0.81%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):